Results 231 to 240 of about 333,660 (389)

A case of hepatocellular carcinoma with pulmonary tumor emboli ; Double carrier of HBV and HTLV-I.

, 1987
Junji Shibata, Saburo Iida, Shigetoshi Fujiyama, Katsuro Sagara, Tatsuo Sato   +4 more
openalex   +2 more sources

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing

The Brazilian Journal of Infectious Diseases, 2016
Bottecchia, Marcelle, Barcaiu, Halime Silva, Lewis-Ximenez, Lia Laura, da Silva e Mouta Junior, Sergio, de Moraes, Marcia Terezinha Baroni   +4 more
openaire   +5 more sources

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

Alimentary Pharmacology &Therapeutics, EarlyView.
Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl, Nirbaanjot Walia, Lukas Hofmann, Lena Wolters, Martin Schulz, Matthias Reinhardt, Brigitta Globke, Frank Tacke, Thomas Berg, Cornelius Engelmann   +9 more
wiley   +1 more source

The lignan compound matairesinol monoglucoside induces type I interferon production in HBV infection immunity by regulating STING signaling. [PDF]

RSC Med Chem
Lin M, Su Z, Zeng D, Liu J, Zheng M, Guo R.   +5 more
europepmc   +1 more source

Studies on the HBV Carriers Superinfected with HDV

, 1988
Ikuo Tamura, Hiroshi Ichimura, Yoshiharu Itoh, Osamu Kurimura, T Kurimura   +4 more
openalex   +2 more sources

The use of polymerase chain reaction (PCR) in the detection and characterization of HBV variants [PDF]

, 1996
Scott G. Baginski, Stephan Günther, Petra Reinke, Detlev H. Krüger, Hans Will, H Meisel   +5 more
openalex   +1 more source

Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose

Gut, 2018
D. Candotti, S. Assennato, S. Laperche, J. Allain, S. Levicnik-Stezinar   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Alimentary Pharmacology &Therapeutics, EarlyView.
In East Asian patients with chronic hepatitis B, rates of virologic suppression through 5 years were high in those treated continuously with tenofovir alafenamide (TAF) and in those switched from tenofovir disoproxil fumarate (TDF) to TAF. Improved renal and bone safety was observed in patients switching from TDF to TAF.
Grace Lai‐Hung Wong, Edward Gane, Calvin Q. Pan, Scott Fung, Mang M. Ma, Namiki Izumi, Shalimar, Seng Gee Lim, Wan‐Long Chuang, Rajiv Mehta, Young‐Suk Lim, Leland J. Yee, John F. Flaherty, Frida Abramov, Hongyuan Wang, Maria Buti   +15 more
wiley   +1 more source

Risk of HBV transmission from HBcAb-positive grafts in pediatric liver transplantation: a real-world prospective cohort study. [PDF]

Virol J
Yang Y, Wu G, Dai X, Zhang T, Tan B, Lu Y, Zhang M, Zhao Y.   +7 more
europepmc   +1 more source

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas [PDF]

, 1998
Qin Su, Claus H. Schröder, Walter Hofmann, Gerd Otto, R. Pichlmayr, Peter Bannasch   +5 more
openalex   +1 more source